Follow
Mehfuz Zaman
Mehfuz Zaman
Research fellow. Institute for Glycomics, Griffith University, Gold Coast, QLD
Verified email at griffith.edu.au
Title
Cited by
Cited by
Year
Polyacrylate dendrimer nanoparticles: a self‐adjuvanting vaccine delivery system
M Skwarczynski, M Zaman, CN Urbani, IC Lin, Z Jia, MR Batzloff, ...
Angewandte Chemie International Edition 49 (33), 5742-5745, 2010
2122010
Nanovaccines and their mode of action
M Zaman, MF Good, I Toth
Methods 60 (3), 226-231, 2013
1672013
Strategies for intranasal delivery of vaccines
M Zaman, S Chandrudu, I Toth
Drug delivery and translational research 3, 100-109, 2013
1332013
Liposome-based delivery system for vaccine candidates: constructing an effective formulation
AK Giddam, M Zaman, M Skwarczynski, I Toth
Nanomedicine 7 (12), 1877-1893, 2012
1292012
Liposomes as nanovaccine delivery systems
K Abdul Ghaffar, A Kumar Giddam, M Zaman, M Skwarczynski, I Toth
Current topics in medicinal chemistry 14 (9), 1194-1208, 2014
1182014
Immunostimulation by synthetic lipopeptide-based vaccine candidates: structure-activity relationships
M Zaman, I Toth
Frontiers in immunology 4, 64366, 2013
1022013
Self-adjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine
M Zaman, M Skwarczynski, JM Malcolm, CN Urbani, Z Jia, MR Batzloff, ...
Nanomedicine: Nanotechnology, Biology and Medicine 7 (2), 168-173, 2011
942011
Polyacrylate-based delivery system for self-adjuvanting anticancer peptide vaccine
TY Liu, WM Hussein, AK Giddam, Z Jia, JM Reiman, M Zaman, ...
Journal of medicinal chemistry 58 (2), 888-896, 2015
692015
Polymer–peptide hybrids as a highly immunogenic single-dose nanovaccine
AAH Ahmad Fuaad, Z Jia, M Zaman, J Hartas, ZM Ziora, IC Lin, PM Moyle, ...
Nanomedicine 9 (1), 35-43, 2014
572014
Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationship
M Zaman, ABM Abdel-Aal, Y Fujita, KSM Phillipps, MR Batzloff, MF Good, ...
PloS one 7 (1), e30146, 2012
532012
Structure–activity relationship for the development of a self-adjuvanting mucosally active lipopeptide vaccine against Streptococcus pyogenes
M Zaman, ABM Abdel-Aal, Y Fujita, ZM Ziora, MR Batzloff, MF Good, ...
Journal of Medicinal Chemistry 55 (19), 8515-8523, 2012
522012
Structure–activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2
M Zaman, ABM Abdel-Aal, KSM Phillipps, Y Fujita, MF Good, I Toth
Vaccine 28 (10), 2243-2248, 2010
512010
Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity
M Zaman, S Chandrudu, AK Giddam, J Reiman, M Skwarczynski, ...
Nanomedicine 9 (17), 2613-2624, 2014
472014
Design of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based toll-like receptor 2 ligand
ABM Abdel-Aal, D El-Naggar, M Zaman, M Batzloff, I Toth
Journal of medicinal chemistry 55 (15), 6968-6974, 2012
462012
Design of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components
ABM Abdel-Aal, M Zaman, Y Fujita, MR Batzloff, MF Good, I Toth
Journal of medicinal chemistry 53 (22), 8041-8046, 2010
432010
Novel platform technology for modular mucosal vaccine that protects against streptococcus
M Zaman, V Ozberk, EL Langshaw, V McPhun, JL Powell, ZN Phillips, ...
Scientific reports 6 (1), 39274, 2016
362016
Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial
M Pandey, J Powell, A Calcutt, M Zaman, ZN Phillips, MF Ho, MR Batzloff, ...
Scientific reports 7 (1), 13786, 2017
302017
Lipo-peptides/saccharides in peptide vaccine delivery
M Skwarczynskim, M Zaman, I Toth
Academic Press/Elsevier, 2013
302013
A semi-synthetic whole parasite vaccine designed to protect against blood stage malaria
AK Giddam, JM Reiman, M Zaman, M Skwarczynski, I Toth, MF Good
Acta biomaterialia 44, 295-303, 2016
282016
Synthetic polyacrylate polymers as particulate intranasal vaccine delivery systems for the induction of mucosal immune response
M Zaman, P Simerska, I Toth
Current drug delivery 7 (2), 118-124, 2010
262010
The system can't perform the operation now. Try again later.
Articles 1–20